Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew H Ko

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Progress in the treatment of metastatic pancreatic cancer and the search for next opportunitiesAndrew H Ko
Seminars in Oncology|August 7, 2007
Future strategies for targeted therapies and tailored patient management in pancreatic cancerAndrew H Ko
International Journal of Nanomedicine|April 22, 2016
Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecanAndrew H Ko
Cancer Journal (Sudbury, Mass.)|December 1, 2017
Clinical Management: Metastatic DiseaseAndrew H Ko
Chinese Clinical Oncology|July 15, 2017
Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017Pelin Cinar, Andrew H Ko
Future Oncology (London, England)|December 22, 2015
MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancerJulia Carnevale, Andrew H Ko
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Evolving treatment options for locally advanced unresectable pancreatic ductal adenocarcinomaPelin Cinar, Andrew H Ko
Leukemia & Lymphoma|April 11, 2003
Clinical outcomes associated with very late relapses in diffuse large cell lymphomaAndrew H Ko, Alan R Yuen
Seminars in Radiation Oncology|September 27, 2005
Systemic therapy for pancreatic cancerAndrew H Ko, Margaret A Tempero
Journal of the National Comprehensive Cancer Network : JNCCN|October 1, 2005
Treatment of metastatic pancreatic cancerAndrew H Ko, Margaret A Tempero
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Progress in the treatment of metastatic pancreatic cancer and the search for next opportunitiesAndrew H Ko
Seminars in Oncology|August 7, 2007
Future strategies for targeted therapies and tailored patient management in pancreatic cancerAndrew H Ko
International Journal of Nanomedicine|April 22, 2016
Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecanAndrew H Ko
Cancer Journal (Sudbury, Mass.)|December 1, 2017
Clinical Management: Metastatic DiseaseAndrew H Ko
Chinese Clinical Oncology|July 15, 2017
Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017Pelin Cinar, Andrew H Ko
Future Oncology (London, England)|December 22, 2015
MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancerJulia Carnevale, Andrew H Ko
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Evolving treatment options for locally advanced unresectable pancreatic ductal adenocarcinomaPelin Cinar, Andrew H Ko
Leukemia & Lymphoma|April 11, 2003
Clinical outcomes associated with very late relapses in diffuse large cell lymphomaAndrew H Ko, Alan R Yuen
Seminars in Radiation Oncology|September 27, 2005
Systemic therapy for pancreatic cancerAndrew H Ko, Margaret A Tempero
Journal of the National Comprehensive Cancer Network : JNCCN|October 1, 2005
Treatment of metastatic pancreatic cancerAndrew H Ko, Margaret A Tempero
Pageof 10